GSK2330672/linerixibat 40 mg

( DrugBank: GSK-2330672 / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
93	原発性胆汁性胆管炎	2

93. 原発性胆汁性胆管炎

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-000007-21-GR (EUCTR)	28/06/2022	11/05/2022	Global Linerixibat Itch STudy of Efficacy and Safety iN PBC (GLISTEN)	A two-part, randomized, placebo controlled, double blind, multicenter, Phase 3 study to evaluate the ...	Moderate to severe Cholestatic pruritus with primary biliary cholangitis (PBC). MedDRA version: 24.1 ...	Product Name: GSK2330672/linerixibat 40 mg Product Code: GSK2330672/linerixibat 40 mg INN or Proposed ...	GlaxoSmithKline Research & Development Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	230	Phase 3	United States;Czechia;Greece;Russian Federation;Israel;United Kingdom;Italy;Switzerland;France;Mexic ...
2	EUCTR2021-000007-21-CZ (EUCTR)	23/06/2022	12/04/2022	Global Linerixibat Itch STudy of Efficacy and Safety iN PBC (GLISTEN)	A two-part, randomized, placebo controlled, double blind, multicenter, Phase 3 study to evaluate the ...	Moderate to severe Cholestatic pruritus with primary biliary cholangitis (PBC). MedDRA version: 24.1 ...	Product Name: GSK2330672/linerixibat 40 mg Product Code: GSK2330672/linerixibat 40 mg INN or Proposed ...	GlaxoSmithKline Research & Development Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	230	Phase 3	United States;Czechia;Greece;Israel;Russian Federation;Switzerland;United Kingdom;Italy;France;Czech ...

First Previous1Next Last